The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC7901 human gastric cancer cells

BACKGROUND: Arsenic trioxide has been established as a first-line agent for treating acute promyelocytic leukemia. Experimental data suggest that arsenic trioxide also can have a potential use as chemotherapeutic agent for other malignancies. The precise mechanisms of action of arsenic trioxide have...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yihu, Zhou, Mengtao, Ye, Aifang, Li, Qiu, Bai, Yongheng, Zhang, Qiyu
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873337/
https://www.ncbi.nlm.nih.gov/pubmed/20403207
http://dx.doi.org/10.1186/1477-7819-8-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873337/
https://www.ncbi.nlm.nih.gov/pubmed/20403207
http://dx.doi.org/10.1186/1477-7819-8-31

Ejemplares similares